Cited by 1,425Brain Metastases and TreatmentManagement of metastatic bone diseaseCancer survivorship and care

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Open access

Sperduto, Paul W., Kased, Norbert, Roberge, David, Xu, Zhiyuan, Shanley, Ryan, Luo, Xianghua, Sneed, Penny K., Chao, Samuel T., Weil, Robert J., Suh, John, Bhatt, Amit, Jensen, Ashley W., Brown, Paul D., Shih, Helen A., Kirkpatrick, John, Gaspar, Laurie E., Fiveash, John B., Chiang, Veronica, Knisely, Jonathan P.S., Sperduto, Christina Maria, Lin, Nancy, Mehta, Minesh·2012·Journal of Clinical Oncology

DOI 10.1200/jco.2011.38.0527PMC PMC3269967

Open this paper in CoChat — free account

Abstract

PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The purpose of this report is to present the updated diagnosis-specific GPA indices in a single, unified, user-friendly report to allow ease of access and use by treating physicians. METHODS: A multi-institutional retrospective (1985 to 2007) database of 3,940 patients with newly diagnosed brain metastases underwent univariate and multivariate analyses of prognostic factors associated with outcomes by primary site and treatment. Significant prognostic factors were used to define the diagnosis-specific GPA prognostic indices. A GPA of 4.0 correlates with the best prognosis, whereas a GPA of 0.0 corresponds with the worst prognosis. RESULTS: Significant prognostic factors varied by diagnosis. For lung cancer, prognostic factors were Karnofsky performance score, age, presence of extracranial metastases, and number of brain metastases, confirming the original Lung-GPA. For melanoma and renal cell cancer, prognostic factors were Karnofsky performance score and the number of brain metastases. For breast cancer, prognostic factors were tumor subtype, Karnofsky performance score, and age. For GI cancer, the only prognostic factor was the Karnofsky performance score. The median survival times by GPA score and diagnosis were determined. CONCLUSION: Prognostic factors for patients with brain metastases vary by diagnosis, and for each diagnosis, a robust separation into different GPA scores was discerned, implying considerable heterogeneity in outcome, even within a single tumor type. In summary, these indices and related worksheet provide an accurate and facile diagnosis-specific tool to estimate survival, potentially select appropriate treatment, and stratify clinical trials for patients with brain metastases.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.38.0527

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548
Self-citation
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citation
An Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987
Self-citation
Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531
Self-citation
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367
Self-citation

Flagged first, then by citations

Show all 21 references

Research works printed but not linked: 1

Therneau TM, 1997, Technical Report 61

Sorted by citations

Items 301–400 of 1,000

PET imaging for brain tumor diagnostics
Suchorska, B., Tonn, J. C., & Jansen, N. L. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000143 · Cited by 36
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib
Yao, Z.-H., Liao, W., Ho, C., Chen, K., Shih, J., Chen, J., Lin, Z., Lin, C., Yang, J. C., & Yu, C. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0331 · Cited by 36
Patterns of Spread and Prognostic Implications of Lung Cancer Metastasis in an Era of Driver Mutations
Hsu, F., Caluwé, A. D., Anderson, D., Nichol, A., Toriumi, T., & Ho, C. (2017) · Current Oncology · doi:10.3747/co.24.3496 · Cited by 36
Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy
Kerkhof, M., Ganeff, I., Wiggenraad, R. G. J., Nijeholt, G. J. L. À., Hammer, S., TAPHOORN, M. J. B., Dirven, L., & Vos, M. J. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2779-7 · Cited by 36
Management of Brain Metastases in ALK-Positive Non–Small-Cell Lung Cancer
Rusthoven, C. G., & Doebele, R. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.2410 · Cited by 35
The Effects of smoking status and smoking history on patients with brain metastases from lung cancer
Shenker, R. F., McTyre, E., Ruiz, J., Weaver, K. E., Cramer, C. K., Alphonse‐Sullivan, N. K., Farris, M. K., Petty, W. J., Bonomi, M. R., Watabe, K., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1058 · Cited by 35
Impact of EGFR mutation and ALK rearrangement on the outcomes of non–small cell lung cancer patients with brain metastasis
Balasubramanian, S. K., Sharma, M., Venur, V. A., Schmitt, P., Kotecha, R. R., Chao, S. T., Suh, J. H., Angelov, L., Mohammadi, A. M., Vogelbaum, M. A., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz155 · Cited by 35
Self-citation
Radiotherapy to the brain: what are the consequences of this age-old treatment?
Wujanto, C., Vellayappan, B. A., Chang, E. L., Chao, S. T., Sahgal, A., & Lo, S. S.-M. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-856 · Cited by 37
Self-citation
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer
Pietrantonio, F., Aprile, G., Rimassa, L., Franco, P., Lonardi, S., Cremolini, C., Biondani, P., Sbicego, E. L., Pasqualetti, F., Tomasello, G., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.08.023 · Cited by 35
Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement
Nieder, C., Marienhagen, K., Dalhaug, A., Aandahl, G., Haukland, E. C., & Pawinski, A. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.03.006 · Cited by 35
miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers
Remón, J., Álvarez-Berdugo, D., Majem, M., Morán, T., Reguart, N., & LIANES, P. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1347-2 · Cited by 35
Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone
Likhacheva, A., Pinnix, C. C., Parikh, N. R., Allen, P. K., Guha‐Thakurta, N., McAleer, M. F., Sulman, E. P., Mahajan, A., Shiu, A. S., Luo, D., et al. (2012) · Journal of neurosurgery · doi:10.3171/2012.3.gks1289 · Cited by 34
Self-citation
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation
Nardone, V., Tini, P., Biondi, M., Sebaste, L., Vanzi, E., Otto, G. D., Rubino, G. F., Carfagno, T., Battaglia, G., Pastina, P., et al. (2016) · Cureus · doi:10.7759/cureus.584 · Cited by 34
The impact of tumor biology on survival and response to radiation therapy among patients with non–small cell lung cancer brain metastases
Miller, J. A., Kotecha, R. R., Ahluwalia, M. S., Mohammadi, A. M., Suh, J. H., Barnett, G. H., Murphy, E. S., Vogelbaum, M. A., Angelov, L., & Chao, S. T. (2017) · Practical Radiation Oncology · doi:10.1016/j.prro.2017.01.001 · Cited by 34
Self-citation
Radiobiology and radiotherapy of brain metastases
Thiagarajan, A., & Yamada, Y. J. (2017) · Clinical & Experimental Metastasis · doi:10.1007/s10585-017-9865-7 · Cited by 34
Optimal management of brain metastases in oncogenic-driven non-small cell lung cancer (NSCLC)
Andratschke, N. H., Kraft, J., Nieder, C., Tay, R. Y., Califano, R., Soffietti, R., & Gückenberger, M. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.12.009 · Cited by 35
The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease
den Begin, R. V., Engels, B., Collen, C., de Vin, T., Defauw, A., Dubaere, E., Barbé, K., & Ridder, M. D. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.01.001 · Cited by 34
Neurofilament Light Chain as A Biomarker for Brain Metastases
Winther‐Larsen, A., Hviid, C. V. B., Meldgaard, P., Sørensen, B. S., & Sandfeld‐Paulsen, B. (2020) · Cancers · doi:10.3390/cancers12102852 · Cited by 34
Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression
Wakuda, K., Yabe, M., Kodama, H., Nishioka, N., Miyawaki, T., Miyawaki, E., Mamesaya, N., Kawamura, T., Kobayashi, H., Omori, S., et al. (2020) · Lung Cancer · doi:10.1016/j.lungcan.2020.11.009 · Cited by 34
Brain Metastases
Aizer, A. A., & Lee, E. Q. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.04.010 · Cited by 34
Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases
Oishi, T., Ito, M., Koizumi, S., Horikawa, M., Yamamoto, T., Yamagishi, S., Yamasaki, T., Sameshima, T., Suzuki, T., Sugimura, H., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.07.001 · Cited by 34
Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients
Mao, W., Fan, Y., Fang, L., Miu, L., Lin, N., Gong, L., Yu, H., Yang, H., & Huang, Z. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s52172 · Cited by 34
Self-citation
Systematic Review of Brain Metastases in Patients With Non–Small-Cell Lung Cancer in the United States, European Union, and Japan
Fenske, D. C., Price, G. L., Hess, L. M., John, W. J., & Kim, E. S. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.04.011 · Cited by 34
Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery
Gao, H. X., Huang, S. G., Du, J., Zhang, X. C., Jiang, N., Kang, W. X., Mao, J., & Zhao, Q. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.28608 · Cited by 35
CNS Metastases in Patients With Non–Small-Cell Lung Cancer and ALK Gene Rearrangement
Shi, W., & Dicker, A. P. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.9682 · Cited by 34
Treatment of Brain Metastases
Lukas, R. V., Gabikian, P., Garza, M., & Chmura, S. J. (2014) · Oncology · doi:10.1159/000362389 · Cited by 33
Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
Bergen, E. S., Binter, A., Starzer, A. M., Heller, G., Kiesel, B., Tendl-Schulz, K., Bagó-Horváth, Z., Furtner, J., Leitner, J., Exner, R., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211009002 · Cited by 33
Are spine metastasis survival scoring systems outdated and do they underestimate life expectancy? Caution in surgical recommendation guidance
Tabourel, G., Terrier, L., Dubory, A., Cristini, J., Nail, L. L., Cook, A., Buffenoir, K., Pascal‐Moussellard, H., Carpentier, A. C., Mathon, B., et al. (2021) · Journal of Neurosurgery Spine · doi:10.3171/2020.12.spine201741 · Cited by 33
Diagnosis-specific graded prognostic assessment score is valid in patients with brain metastases treated in routine clinical practice in two European countries
Nieder, C., Andratschke, N. H., Geinitz, H., & Grosu, A. (2012) · Medical Science Monitor · doi:10.12659/msm.883213 · Cited by 33
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis
Loi, M., Caini, S., Scoccianti, S., Bonomo, P., Vries, K. D., Francolini, G., Simontacchi, G., Greto, D., Desideri, I., Meattini, I., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103043 · Cited by 32
Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer
Wang, W., He, H., Marín‐Ramos, N. I., Zeng, S., Swenson, S., Cho, H., Fu, J., Beringer, P. M., Neman, J., Chen, L., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab041 · Cited by 32
Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for Patients
Alvarez-Breckenridge, C. A., Remón, J., Piña, Y., Nieblas‐Bedolla, E., Forsyth, P. A., Hendriks, L. E. L., & Brastianos, P. K. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_352320 · Cited by 32
Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy
Xie, D., Xu, F., Zhu, W., Pu, C., Huang, S., Lou, K., Wu, Y., Huang, D., He, C., & Hu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.990608 · Cited by 32
Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery
Taunk, N. K., Oh, J. H., Shukla‐Dave, A., Beal, K. P., Vachha, B. A., Holodny, A. I., & Hatzoglou, V. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox159 · Cited by 32
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)
Chaigneau, L., Patrikidou, A., Ray-Coquard, I. L., Valentin, T., Linassier, C., Bay, J. O., Moureau-Zabotto, L., Bompas, E., Piperno-Neumann, S., Penel, N., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0136 · Cited by 32
Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
Füreder, L. M., Widhalm, G., Gatterbauer, B., Dieckmann, K. U., Hainfellner, J. A., Bartsch, R., Zielinski, C. C., Preusser, M., & Berghoff, A. S. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9947-1 · Cited by 32
Radiomics Method for the Differential Diagnosis of Radionecrosis Versus Progression after Fractionated Stereotactic Body Radiotherapy for Brain Oligometastasis
Hettal, L., Stefani, A., Salleron, J., Courrech, F., Behm‐Ansmant, I., Constans, J., Gauchotte, G., & Vogin, G. (2020) · Radiation Research · doi:10.1667/rr15517.1 · Cited by 32
Management of Brain Metastases
Collier, E. F., Chiang, V., & Goldberg, S. B. (2021) · Current cancer research · doi:10.1007/978-3-030-74028-3_6 · Cited by 32
Self-citation
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival
Zeiner, P. S., Zinke, J., Kowalewski, D. J., Bernatz, S., Tichy, J., Ronellenfitsch, M. W., Thorsen, F., Berger, A., Forster, M.-T., Muller, A., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0521-5 · Cited by 31
New developments in brain metastases
Berghoff, A. S., & Preusser, M. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418785502 · Cited by 31
Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study
Ni, M., Jiang, A., Liu, W., Sheng, Y., Zeng, H., Liu, N., Gao, Q., Wang, Y., Yu, J., & Yuan, S. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01509-3 · Cited by 31
Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study
Fuchs, J., Früh, M., Papachristofilou, A., Bubendorf, L., Haeuptle, P., Jost, L. M., Zippelius, A., & Rothschild, S. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253601 · Cited by 31
Low-Energy X-Ray Intraoperative Radiation Therapy (Lex-IORT) for Resected Brain Metastases: A Single-Institution Experience
Diehl, C., Pigorsch, S. U., Gempt, J., Krieg, S. M., Reitz, S., Waltenberger, M., Barz, M., Meyer, H. S., Wagner, A., Wilkens, J. J., et al. (2022) · Cancers · doi:10.3390/cancers15010014 · Cited by 31
Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease
Li, A. Y., Gaebe, K., Zulfiqar, A., Lee, G. S., Jerzak, K. J., Sahgal, A., Habbous, S., Erickson, A. W., & Das, S. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0475 · Cited by 33
TME-targeted approaches of brain metastases and its clinical therapeutic evidence
Khan, I. M., Khan, S. U., Sala, H. S. S., Khan, M. U., Din, M. A. U., Khan, S., Hassan, S. S. U., Khan, N. M., & Liu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1131874 · Cited by 31
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS)
Tini, P., Nardone, V., Pastina, P., Battaglia, G., Vinciguerra, C., Carfagno, T., Rubino, G. F., Carbone, S. F., Sebaste, L., Cerase, A., et al. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2876-y · Cited by 31
Efficacy and Safety of Radiotherapy Plus EGFR-TKIs in NSCLC Patients with Brain Metastases: A Meta-Analysis of Published Data
Wang, X., Xu, Y., Tang, W., & Liu, L. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.07.003 · Cited by 31
Immunotherapy Plus Surgery/Radiosurgery is Associated with Favorable Survival in Patients with Melanoma Brain Metastasis
Amaral, T. M. S., Tampouri, I., Eigentler, T., Keim, U., Klumpp, B. D., Heinrich, V., Zips, D., Paulsen, F., Gepfner‐Tuma, I., Skardelly, M., et al. (2019) · Immunotherapy · doi:10.2217/imt-2018-0149 · Cited by 31
Whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases: a multicenter, open-label, randomized, controlled phase III trial
Yang, Z., Zhang, Y., Li, R., Abulimiti, Y., Ren, B., Sun, J., Li, J., Chen, L., Zhao, R., Zhang, J., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa281 · Cited by 31
Psoroptic Ear Mites in Dairy Goats
Williams, J. F., & Williams, C. S. F. (1978) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1978.173.12.1582 · Cited by 31
Brain metastasis DNA methylomes, a novel resource for the identification of biological and clinical features
Salomon, M. P., Orozco, J. I. J., Wilmott, J. S., Hothi, P., Manughian-Peter, A. O., Cobbs, C., Scolyer, R. A., Hoon, D. S. �., & Marzese, D. M. (2018) · Scientific Data · doi:10.1038/sdata.2018.245 · Cited by 31
Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases
Haque, W. M., Verma, V., Butler, E. B., & Teh, B. S. (2018) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2018.03.015 · Cited by 30
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
Lim, M., Puttick, S. G., Houston, Z. H., Thurecht, K. J., Croft, P. K., Mahler, S. M., Rose, S., Jeffree, R. L., Mazzieri, R., Dolcetti, R., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061280 · Cited by 32
Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
Zhao, B., Wang, Y., Wang, Y., Chen, W., Zhou, L., Liu, P. H., Kong, Z., Dai, C., Wang, Y., & Ma, W. (2020) · Aging · doi:10.18632/aging.103455 · Cited by 30
Prognostic significance of molecular subtype, metastatic site and primary tumor surgery for survival in primary metastatic breast cancer
Li, Y., Wang, S., Yang, W., & Liu, H. (2021) · Medicine · doi:10.1097/md.0000000000026619 · Cited by 30
Radiomics outperforms semantic features for prediction of response to stereotactic radiosurgery in brain metastases
Gutsche, R., Lohmann, P., Hoevels, M., Ruess, D. F., Galldiks, N., Visser-Vandewalle, V. E. R. M., Treuer, H., Ruge, M. I., & Köcher, M. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.11.010 · Cited by 30
Optimal Management of Brain Metastases from Breast Cancer
Bartsch, R., Berghoff, A. S., & Preusser, M. (2012) · CNS Drugs · doi:10.1007/s40263-012-0024-z · Cited by 30
Non‐small cell lung cancer brain metastasis screening in the era of positron emission tomography‐ CT staging: Current practice and outcomes
Diaz, M. E., Debowski, M., Hukins, C., Fielding, D. I., Fong, K. M., & Bettington, C. S. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12732 · Cited by 30
Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
Sun, H., Xu, L., Wang, Y., Zhao, J., Xu, K., Qi, J., Yuan, Z., Zhao, L., & Wang, P. (2018) · Radiation Oncology · doi:10.1186/s13014-018-1198-4 · Cited by 30
Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
Pino, I. P., & Chen, C. C. (2023) · Asian Journal of Neurosurgery · doi:10.1055/s-0043-1769754 · Cited by 31
Institutional, Retrospective Analysis of 777 Patients With Brain Metastases: Treatment Outcomes and Diagnosis-Specific Prognostic Factors
Antoni, D., Clavier, J.-B., Pop, M., Schumacher, C., Lefebvre, F., & Noël, G. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.02.027 · Cited by 29
The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: The US Survey of Utilization of Memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases
Slade, A. N., & Stanic, S. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.12.013 · Cited by 29
Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients
Gregucci, F., Fiorentino, A., Corradini, S., Figlia, V., Mazzola, R., Ricchetti, F., Ruggieri, R., & Alongi, F. (2018) · Strahlentherapie und Onkologie · doi:10.1007/s00066-018-1405-0 · Cited by 30
Circulating Exosomal Integrin β3 Is Associated with Intracranial Failure and Survival in Lung Cancer Patients Receiving Cranial Irradiation for Brain Metastases: A Prospective Observational Study
Chen, G.-Y., Cheng, J. C., Chen, Y., Yang, J. C., & Hsu, F. (2021) · Cancers · doi:10.3390/cancers13030380 · Cited by 29
Research Progress and Challenges in the Treatment of Central Nervous System Metastasis of Non-Small Cell Lung Cancer
Wang, B., Guo, H., Xu, H., Yu, H., Chen, Y., & Zhao, G. (2021) · Cells · doi:10.3390/cells10102620 · Cited by 29
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer
Chen, T. W., Dai, M., Tseng, L., Chen, S., Chao, T., Chao, T., Chang, Y., Chiu, C., Liu, C.-T., Lin, C., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.5456 · Cited by 29
Alleviation of Brain Edema and Restoration of Functional Independence by Bevacizumab in Brain-Metastatic Breast Cancer: A Case Report
Berghoff, A. S., Sax, C., Klein, M., Furtner, J., Dieckmann, K. U., Gatterbauer, B., Widhalm, G., Rudas, M., Zielinski, C. C., Bartsch, R., et al. (2014) · Breast Care · doi:10.1159/000360930 · Cited by 29
Amplification and overexpression of CMET is a common event in brain metastases of non‐small cell lung cancer
Preusser, M., Streubel, B., Berghoff, A. S., Hainfellner, J. A., von Deimling, A., Widhalm, G., Dieckmann, K. U., Wöehrer, A., Hackl, M., Zielinski, C. C., et al. (2014) · Histopathology · doi:10.1111/his.12475 · Cited by 29
Stereotactic radiosurgery for brain metastases from malignant melanoma
Kasper, E. M., Lam, F. C., Mahadevan, A., Wong, E., Chen, C. C., Christ, S., & Floyd, S. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.163315 · Cited by 29
Survival of Patients With Multiple Intracranial Metastases Treated With Stereotactic Radiosurgery
Knoll, M. A., Oermann, E. K., Yang, A. I., Paydar, I., Steinberger, J. M., Collins, B. T., Collins, S., Ewend, M. G., & Kondziolka, D. S. (2016) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000299 · Cited by 29
Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases
Hirshman, B. R., Wilson, B. R., Ali, M. A., Schüpper, A. J., Proudfoot, J., Goetsch, S. J., Carter, B. S., Sinclair, G., Bartek, J. J., Chiang, V., et al. (2017) · Neurosurgery · doi:10.1093/neuros/nyx380 · Cited by 29
Self-citation
The role of whole brain radiation therapy in the management of melanoma brain metastases
Dyer, M. A., Arvold, N. D., Chen, Y., Pinnell, N. E., Митин, Т., Lee, E. Q., Hodi, F. S., Ibrahim, N., Weiss, S. E., Kelly, P. J., et al. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-143 · Cited by 28
Targeted Therapies for Melanoma Brain Metastases
Berghoff, A. S., & Preusser, M. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0449-2 · Cited by 28
Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients
Masel, E. K., Berghoff, A. S., Füreder, L. M., Heicappell, P., Schlieter, F., Widhalm, G., Gatterbauer, B., Dieckmann, U., Birner, P., Bartsch, R., et al. (2017) · European Journal of Cancer Care · doi:10.1111/ecc.12707 · Cited by 28
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Sperduto, P. W., Deegan, B. J., Li, J., Jethwa, K. R., Brown, P. D., Lockney, N. A., Beal, K. P., Rana, N., Attia, A. A., Tseng, C., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.04.006 · Cited by 28
Self-citation
Breast cancer patients with brain metastases or leptomeningeal disease: 10‐year results of a national cohort with validation of prognostic indexes
Žnidarič, T., Gugic, J., Marinko, T., Horvat, A. G., Kosir, M. S. P., Golo, D., Pantar, M. I., & Ratoša, I. (2019) · The Breast Journal · doi:10.1111/tbj.13433 · Cited by 28
Management of Brain and Leptomeningeal Metastases from Breast Cancer
Pellerino, A., Internò, V., Mo, F., Franchino, F., Soffietti, R., & Rudà, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228534 · Cited by 28
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors
Berghoff, A. S., Bagó-Horváth, Z., Ilhan‐Mutlu, A., Magerle, M., Dieckmann, K. U., Marosi, C., Birner, P., Widhalm, G., Steger, G. G., Zielinski, C. C., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.440 · Cited by 28
A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases
Yin, K., Li, Y.-S., Zheng, M.-M., Jiang, B., Li, W., Yang, J., Tu, H., Zhou, Q. H., Zhong, W., Yang, X., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.03.015 · Cited by 28
Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer
Zhou, L., Liu, J., Xue, J., Xu, Y., Gong, Y., Deng, L., Wang, S., Zhong, R., Ding, Z., & Lü, Y. (2014) · Radiation Oncology · doi:10.1186/1748-717x-9-117 · Cited by 28
Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC
Liu, J., Cai, Y., He, Y.-Z., Xu, J., Tian, S.-F., & Li, Z. (2024) · BMC Cancer · doi:10.1186/s12885-024-11875-w · Cited by 28
Prognostic Factors for stereotactic radiosurgery-treated patients with cerebral metastasis: Implications on randomised control trial design and inter-institutional collaboration
Gonda, D. D., Kim, T. E., Goetsch, S., Kawabe, T., Watanabe, S., Alksne, J. F., Hattangadi, J. A., Nitta, M., Ott, K. H., Hodgens, D. W., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.001 · Cited by 27
The strategy of repeat stereotactic radiosurgery without whole brain radiation treatment for new brain metastases: Outcomes and implications for follow-up monitoring
Shen, C. J., Rigamonti, D., Redmond, K. J., Kummerlowe, M. N., Lim, M. K., & Kleinberg, L. R. (2016) · Practical Radiation Oncology · doi:10.1016/j.prro.2016.04.004 · Cited by 28
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
Isaksson, J., Berglund, A., Louie, K. S., Willén, L., Hamidian, A., Edsjö, A., Enlund, F., Planck, M., Vikström, A., Johansson, M., et al. (2023) · Clinical Lung Cancer · doi:10.1016/j.cllc.2023.05.002 · Cited by 27
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2)
Feilchenfeldt, J. W., Varga, Z., Siano, M., Grabsch, H. I., Held, U., Schuknecht, B., Trip, A. K., Hamaguchi, T., Gut, P., Balagué, O., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.279 · Cited by 27
New Developments in Intracranial Stereotactic Radiotherapy for Metastases
Pinkham, M. B., Whitfield, G. A., & Brada, M. (2015) · Clinical Oncology · doi:10.1016/j.clon.2015.01.007 · Cited by 28
Molecular Subtyping of Brain Metastases and Implications for Therapy
Renfrow, J. J., & Lesser, G. J. (2013) · Current Treatment Options in Oncology · doi:10.1007/s11864-013-0248-2 · Cited by 27
A cure is possible: a study of 10-year survivors of brain metastases
Kotecha, R. R., Vogel, S. J., Suh, J. H., Barnett, G. H., Murphy, E. S., Reddy, C. A., Parsons, M. W., Vogelbaum, M. A., Angelov, L., Mohammadi, A. M., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2208-8 · Cited by 27
Self-citation
Predicting prognosis of short survival time after palliative whole-brain radiotherapy
Miyazawa, K., Shikama, N., Okazaki, S., Koyama, T., Takahashi, T., & Kato, S. (2017) · Journal of Radiation Research · doi:10.1093/jrr/rrx058 · Cited by 27
Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Wolpert, F., Weller, M., Berghoff, A. S., Rushing, E. J., Füreder, L. M., Petyt, G., Leske, H., Andratschke, N. H., Regli, L., Neidert, M. C., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.03.010 · Cited by 28
Peritumoral Edema/Tumor Volume Ratio: A Strong Survival Predictor for Posterior Fossa Metastases
Calluaud, G., Terrier, L., Mathon, B., Destrieux, C., Velut, S., François, P., Zemmoura, I., & Amelot, A. (2018) · Neurosurgery · doi:10.1093/neuros/nyy222 · Cited by 27
ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
Jin, X., Jia, Y., Shi, Y., Li, Q., Bao, S., Lü, W., & Tong, Z. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27146 · Cited by 27
The effect of brain metastasis location on clinical outcomes: A review of the literature
Kancharla, P., Ivanov, A., Chan, S., Ashamalla, H. L., Huang, R. Y., & Yanagihara, T. K. (2019) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdz017 · Cited by 27
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival
Thurmaier, J., Heinemann, V., Engel, J., Schubert-Fritschle, G., Wiedemann, M., Nüssler, N. C., Ruppert, R., Kleeff, J. H., Schepp, W., Löhe, F., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33364 · Cited by 27
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
Berghoff, A. S., Breckwoldt, M. O., Riedemann, L., Jazi, K. K., Löw, S., Schlieter, F., Furtner, J., Cinci, M., Thomas, M., Strowitzki, M. J., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa038 · Cited by 26
Brain metastases of lung cancer: comparison of survival outcomes among whole brain radiotherapy, whole brain radiotherapy with consecutive boost, and simultaneous integrated boost
Du, T., Li, X., Zhong, W.-S., Tian, J.-D., Zhao, Y., & Liu, D. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03359-8 · Cited by 26
Survival benefit of anti-HER2 therapy after whole-brain radiotherapy in HER2-positive breast cancer patients with brain metastasis
Zhang, Q., Chen, J., 俞晓立, Cai, G., 杨兆知, Cao, L., Hu, C., 郭小毛, Sun, J., & Chen, J. (2015) · Breast Cancer · doi:10.1007/s12282-015-0631-x · Cited by 26
Pharmacotherapeutic options for treating brain metastases in non-small cell lung cancer
Metro, G., Chiari, R., Ricciuti, B., Rebonato, A., Lupattelli, M., Gori, S., Bennati, C., Castrioto, C., Floridi, P., Minotti, V., et al. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1094056 · Cited by 26
Brain metastasis from renal cell carcinoma
Bennani, O., Derrey, S., Langlois, O., Castel, H., Laquerrière, A., Fréger, P., & Proust, F. (2014) · Neurochirurgie · doi:10.1016/j.neuchi.2013.12.001 · Cited by 26
Systematic review of brain metastases prognostic indices
Rodrigues, G., Bauman, G. S., Palma, D. A., Louie, A. V., Mocanu, J. D., Senan, S., & Lagerwaard, F. J. (2012) · Practical Radiation Oncology · doi:10.1016/j.prro.2012.04.001 · Cited by 26

Authors: Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
Affiliations: University of Minnesota (US)
University of California, San Francisco (US)
McGill University (CA)
Cleveland Clinic (US)
Author affiliations appear at the end of this article.
Mayo Clinic (US)
Harvard University (US)
Duke University (US)
University of Colorado Denver (US)
University of Alabama at Birmingham (US)
Yale University (US)
Hofstra University (US)
Dartmouth College (US)
Northwestern University (US)
ORCID: Sperduto, Paul W.
Kased, Norbert
Roberge, David
Xu, Zhiyuan
Shanley, Ryan
Luo, Xianghua
Sneed, Penny K.
Chao, Samuel T.
Weil, Robert J.
Suh, John
Bhatt, Amit
Brown, Paul D.
Shih, Helen A.
Kirkpatrick, John
Fiveash, John B.
Chiang, Veronica
Knisely, Jonathan P.S.
Mehta, Minesh
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2012-02-01
Volume: 30
Issue: 4
Pages: 419-425
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.38.0527
PMC: PMC3269967
OpenAlex: W1974820090
Cited by: 1,425
References: 21
Citations by year: 2026: 41 · 2025: 57 · 2024: 88 · 2023: 112 · 2022: 103 · 2021: 113 · 2020: 146 · 2019: 117 · 2018: 131 · 2017: 134 · 2016: 115 · 2015: 94 · 2014: 68 · 2013: 62 · 2012: 38
FWCI: 45.80
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30CA-77598, P30CA077598)
Topics: Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords: brain metastases, Graded Prognostic Assessment, prognosis, survival estimation, prognostic factors, lung cancer, melanoma, renal cell carcinoma, breast cancer, gastrointestinal cancer, Karnofsky performance status, extracranial metastases, number of brain metastases, clinical trial stratification
MeSH terms: Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Lung Neoplasms, Male, Melanoma, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Analysis, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks